Cerenome, Inc. (CNSY): Free Cash Flow
-$20.84M
Year ended 2025-12-31
-$28.70M
Trailing 12 months to 2026-09-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$20.84M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$10.70M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$13.01M | n/a | 2025-03-31, From 2023-01-01 |
| No annual figure between 2019-12-31 and 2023-12-31. | |||
| 2019-12-31 | -$5.97M | n/m | 2021-02-22, From 2019-01-01 |
| 2018-12-31 | -$12.11M | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$18.42M | n/m | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | -$19.60M | n/m | 2018-03-09, From 2016-01-01 |
| 2015-12-31 | -$21.08M | n/m | 2017-03-24, From 2015-01-01 |
| 2014-12-31 | -$31.09M | n/m | 2016-03-11, From 2014-01-01 |
| 2013-12-31 | -$35.08M | n/m | 2016-03-11, From 2013-01-01 |
| 2012-12-31 | -$33.40M | n/m | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | -$35.88M | n/m | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | -$24.18M | n/m | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | -$24.03M | n/a | 2012-09-07, From 2009-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Cerenome, Inc. (CNSY) | 2025-12-31 | -$20.84M | n/m |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | -$7.93M | n/a |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | -$8.34M | n/m |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | -$79.08M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $88.9K | n/m |
| Immunome Inc. (IMNM) | 2025-12-31 | -$200.60M | n/m |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | -$97.98M | n/m |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | -$38.33M | n/m |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | -$279.92M | n/m |
Compare CNSY, ENSC, PRPH, KRRO side by side · Screen every company in Pharmaceutical Preparations ↗